CN Patent

CN103694241A — Pci-32765的新晶型a及其制备方法

Assigned to SUZHOU PENGXU PHARMATECH Co Ltd · Expires 2014-04-02 · 12y expired

What this patent protects

本发明提供PCI-32765的新晶型A及其制备方法。所述晶型A，其特征在于X射线粉末衍射图在2theta值为5.2°±0.2°、17.6°±0.2°、22.1°±0.2°、19.3°±0.2°、22.4°±0.2°、20.8°±0.2°、16.2°±0.2°、18.1°±0.2°、18.9°±0.2°、23.0°±0.2°处具有特征峰。

USPTO Abstract

本发明提供PCI-32765的新晶型A及其制备方法。所述晶型A，其特征在于X射线粉末衍射图在2theta值为5.2°±0.2°、17.6°±0.2°、22.1°±0.2°、19.3°±0.2°、22.4°±0.2°、20.8°±0.2°、16.2°±0.2°、18.1°±0.2°、18.9°±0.2°、23.0°±0.2°处具有特征峰。

Drugs covered by this patent

Patent Metadata

Patent number
CN103694241A
Jurisdiction
CN
Classification
—
Expires
2014-04-02
Drug substance claim
No
Drug product claim
No
Assignee
SUZHOU PENGXU PHARMATECH Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.